KEAP1 and STK11/LKB1 alterations enhance vulnerability to ATR inhibition in KRAS mutant non-small cell lung cancer

Journal:
Cancer Cell
Published:
DOI:
10.1016/j.ccell.2025.06.011
Affiliations:
5
Authors:
20
Go to article
Institutions Authors Share
The University of Texas MD Anderson Cancer Center, United States of America (USA)
13.000000
13.000000
 0.65
AstraZeneca Cambridge, United Kingdom (UK)
6.000000
 0.30
Cleveland Clinic, United States of America (USA)
1.000000
 0.05
Interested in Oncology and Carcinogenesis?